FDA FDA Launches Patient First Website Thomas Sullivan Jul 15, 2013 0 Last summer, Congress enacted the Food and Drug Administration Safety and Innovation Act (FDASIA), which included the fifth…
ACCME ACCME Issues Compliance Reminders Thomas Sullivan Jul 12, 2013 0 In its monthly newsletter, the Accreditation Council for Continuing Medical Education (ACCME) noted that it is currently reviewing…
CME AAFP Updates CME Faculty Resource Center Thomas Sullivan Jul 12, 2013 0 The American Academy of Family Physicians (AAFP) Division of Continuing Medical Education (DCME) recently announced that it is…
CME Programs for Physicians Should include Online, Live and Print Options Thomas Sullivan Jul 11, 2013 0 A recent survey from Medical Marketing Service Inc. (MMS) stated that "the key to successful medical direct marketing is listening…
Congress Senator Grassley Asks 50 States for Coordination Procedures with CMS for… Thomas Sullivan Jul 11, 2013 0 Senator Charles Grassley (R-IA), the co-author of the Sunshine Act, recently sent letters to all 50 states this week asking how…
Physician Payment Sunshine Act: Final Rule Physician Payment Sunshine Act and Continuing Medical Education: Answering… Thomas Sullivan Jul 10, 2013 0 Policy and Medicine is hosting a live teleconference and webcast at 1:00pm-2:30pm Eastern Wednesday, July 24th to discuss…
FDA FDA MedWatch Safety and Adverse Event Reporting Program Expands Patient… Thomas Sullivan Jul 10, 2013 0 Earlier this month, the Food and Drug Administration (FDA) celebrated the 20th anniversary of its MedWatch program, which…
FDA FDA: Delay of Online and Social Media Guidance Creates Confusion Thomas Sullivan Jul 9, 2013 0 It has been quite a while since we have written about social media and the Food and Drug Administration (FDA)—mostly because the…
Open Payments Q&A Physician Payment Sunshine Act: CMS Posts Round 4 of FAQs: CME Exemption… Thomas Sullivan Jul 8, 2013 1 The Centers for Medicare & Medicaid Services (CMS) posted additional frequently asked questions (FAQs) on its website for Open…
DOJ DOJ Probing International Pharmaceutical Manufacturing Thomas Sullivan Jul 5, 2013 0 Earlier this year, we noted that a new enforcement focus for the U.S. Department of Justice (DOJ) will be increased oversight to…